ATM Inhibitor-5; KL7B6D38VC; M4076; M-4076; 2020089-41-0; 8-(1,3-Dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-2H-imidazo(4,5-C)quinolin-2-one; 8-(1,3-dimethylpyrazol-4-yl)-1-(3-fluoranyl-5-methoxy-pyridin-4-yl)-7-methoxy-3-methyl-imidazo[4,5-c]quinolin-2-one; Lartesertib; UNII-KL7B6D38VC; SCHEMBL18125397; US10457677, Example 4; BDBM418436; BDBM418555; GLXC-26900; M 4076 [WHO-DD]; EX-A6934; US10457677, Example 150; HY-150617; CS-0534879; 2495096-26-7; 2H-Imidazo(4,5-C)quinolin-2-one, 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-; 8-(1,3-Dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methyl-1,3-dihydro2H-imidazo[4,5-c]quinolin-2-one; 8-(1,3-Dimethylpyrazol-4- yl)-1-[3-fluoro-5-(trideuterio- methoxy)-4-pyridyl]-7- methoxy-3-methyl-imidazo- [4,5-c]quinolin-2-one; UGK